Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-30

FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for trospium chloride submitted by Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROSPIUM CHLORIDE

Snippet

SUPPL AP for TROSPIUM CHLORIDE (TROSPIUM CHLORIDE)